Since March 2020, the outbreak of Sars-CoV-2 pandemic has changed medical practice and
daily routine around the world. Huge efforts from pharmacological industries have led to the …

Background As the COVID-19 pandemic continues worldwide, severe COVID-19 outcomes
remain a major concern for patients with rheumatic and musculoskeletal diseases. We …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has caused more than 100
million infections and 2 million deaths worldwide. In up to 20% of cases, COVID-19 infection …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a
global pandemic of severe coronavirus disease 2019 (COVID-19). Staphylococcus aureus is …

Background COVID-19 can induce a hyperinflammatory state, which might lead to poor
clinical outcomes. We aimed to assess whether patients with a systemic rheumatic disease …

Background The COVID-19 pandemic has raised numerous questions among patients with
immune-mediated inflammatory diseases regarding potential reciprocal effects of COVID-19 …

Objective The coronavirus disease 2019 (COVID-19) pandemic has created multiple
uncertainties regarding rheumatic diseases or their treatment, with regard to the …

Background. Coronavirus disease 2019 (COVID‐19) vaccine hesitancy or refusal has arisen
as a major global public health concern. The aim of this study was to address the attitudes of …

Since January 2020, the whole world has been facing the worst epidemic for a century.
SARS-CoV-2 infection has so far caused more than one million deaths, with the only …

Vaccine hesitancy (VH) has emerged as a recognized threaten to contain the COVID-19
pandemic. Historically, low vaccine acceptance rates had been described among patients …